MedTrace Logo

Study of Bronchodilation Effects of Cetirizine

NCT01781507 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2013-09-04

No results posted yet for this study

Summary

Primary Objective :

To compare the acute bronchodilatory effects of cetirizine 10 mg tablet and nebulized levalbuterol using impulse oscillometry technique in asthmatic subjects aged 18 to 65 years old who have allergic rhinitis and show clinical evidence of bronchial hyper-reactivity.

Secondary Objective:

To assess the bronchodilatory effects of cetirizine 10 mg tablet versus placebo after two weeks of therapy using impulse oscillometry technique in subjects 18 to 65 years old who have allergic rhinitis and show clinical evidence of bronchial hyper-reactivity.

Conditions

Interventions

DRUG

Cetirizine

Cetirizine is an antihistamine currently indicated for allergic rhinitis

DRUG

Placebo

This placebo ( sugar pill) will provide the negative control for this study

Sponsors & Collaborators

  • McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

    collaborator INDUSTRY

  • California Allergy and Asthma Medical Group, Inc.

    lead OTHER

Principal Investigators

  • Sheldon L Spector, MD · California Allergy & Asthma Medical Group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01781507 on ClinicalTrials.gov